SNPHF
Price
$10.53
Change
-$0.62 (-5.56%)
Updated
Dec 9 closing price
SNPHY
Price
$9.68
Change
-$0.20 (-2.02%)
Updated
Dec 23 closing price
Ad is loading...

SNPHF vs SNPHY

Header iconSNPHF vs SNPHY Comparison
Open Charts SNPHF vs SNPHYBanner chart's image
Santen Pharmaceutical
Price$10.53
Change-$0.62 (-5.56%)
Volume$299
CapitalizationN/A
Santen Pharmaceutical
Price$9.68
Change-$0.20 (-2.02%)
Volume$13.97K
CapitalizationN/A
SNPHF vs SNPHY Comparison Chart
Loading...
SNPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNPHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SNPHF vs. SNPHY commentary
Dec 25, 2024

To understand the difference between Santen Pharmaceutical Co. Ltd. (SNPHF) vs. Santen Pharmaceutical Co. Ltd. - ADR (SNPHY) it is enough to know the definitions of ADR

ADR - American depositary receipt (ADR) is a certificate issued by a U.S. depositary bank representing a specified number of shares (often 1 share) of a foreign company's stock. ADRs are denominated in U.S. dollars and trade on U.S. stock markets and OTC depending on the ADRs classification.

Ad is loading...
COMPARISON
Comparison
Dec 25, 2024
Stock price -- (SNPHF: $10.53 vs. SNPHY: $10.93)
Brand notoriety: SNPHF and SNPHY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: SNPHF: 16% vs. SNPHY: 4%
Market capitalization -- SNPHF: $3.26B vs. SNPHY: $3.26B
SNPHF [@Pharmaceuticals: Major] is valued at $3.26B. SNPHY’s [@Pharmaceuticals: Major] market capitalization is $3.26B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNPHF’s FA Score shows that 1 FA rating(s) are green whileSNPHY’s FA Score has 1 green FA rating(s).

  • SNPHF’s FA Score: 1 green, 4 red.
  • SNPHY’s FA Score: 1 green, 4 red.
According to our system of comparison, both SNPHF and SNPHY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNPHF’s TA Score shows that 5 TA indicator(s) are bullish while SNPHY’s TA Score has 2 bullish TA indicator(s).

  • SNPHF’s TA Score: 5 bullish, 2 bearish.
  • SNPHY’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, SNPHF is a better buy in the short-term than SNPHY.

Price Growth

SNPHF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while SNPHY (@Pharmaceuticals: Major) price change was +6.74% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.40%. For the same industry, the average monthly price growth was -2.78%, and the average quarterly price growth was -2.25%.

Industries' Descriptions

@Pharmaceuticals: Major (-1.40% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNPHF($3.26B) and SNPHY($3.26B) have the same market capitalization . SNPHY (15.60) and SNPHF (15.31) have similar P/E ratio . SNPHF YTD gains are higher at: 5.573 vs. SNPHY (-0.649). SNPHF (17.2B) and SNPHY (17.2B) have comparable annual earnings (EBITDA) . SNPHF (62.3B) and SNPHY (62.3B) have equal amount of cash in the bank . SNPHF (40.1B) and SNPHY (40.1B) have identical debt. SNPHF (270B) and SNPHY (270B) have equivalent revenues.
SNPHFSNPHYSNPHF / SNPHY
Capitalization3.26B3.26B100%
EBITDA17.2B17.2B100%
Gain YTD5.573-0.649-859%
P/E Ratio15.3115.6098%
Revenue270B270B100%
Total Cash62.3B62.3B100%
Total Debt40.1B40.1B100%
FUNDAMENTALS RATINGS
SNPHF vs SNPHY: Fundamental Ratings
SNPHF
SNPHY
OUTLOOK RATING
1..100
3484
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
24
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5260
P/E GROWTH RATING
1..100
3550
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNPHY's Valuation (24) in the null industry is in the same range as SNPHF (26). This means that SNPHY’s stock grew similarly to SNPHF’s over the last 12 months.

SNPHY's Profit vs Risk Rating (100) in the null industry is in the same range as SNPHF (100). This means that SNPHY’s stock grew similarly to SNPHF’s over the last 12 months.

SNPHY's SMR Rating (100) in the null industry is in the same range as SNPHF (100). This means that SNPHY’s stock grew similarly to SNPHF’s over the last 12 months.

SNPHF's Price Growth Rating (52) in the null industry is in the same range as SNPHY (60). This means that SNPHF’s stock grew similarly to SNPHY’s over the last 12 months.

SNPHF's P/E Growth Rating (35) in the null industry is in the same range as SNPHY (50). This means that SNPHF’s stock grew similarly to SNPHY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SNPHFSNPHY
RSI
ODDS (%)
Bullish Trend 2 days ago
51%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
49%
Bullish Trend 2 days ago
66%
Momentum
ODDS (%)
Bullish Trend 2 days ago
47%
Bearish Trend 2 days ago
66%
MACD
ODDS (%)
Bullish Trend 2 days ago
44%
Bearish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
43%
Bearish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
31%
Bearish Trend 2 days ago
69%
Advances
ODDS (%)
N/A
Bullish Trend 22 days ago
54%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
67%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
65%
Aroon
ODDS (%)
Bullish Trend 7 days ago
46%
Bearish Trend 2 days ago
69%
View a ticker or compare two or three
Ad is loading...
SNPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNPHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYOCX84.280.85
+1.02%
Rydex NASDAQ-100® Inv
PWITX16.240.10
+0.62%
PACE International Equity Invmt P2
FKEMX38.860.22
+0.57%
Fidelity Emerging Markets K
BAILX10.690.02
+0.19%
Brown Advisory Sustainable Intl Ldrs Ins
LCMGX21.07-0.03
-0.14%
Lord Abbett Micro Cap Growth C

SNPHF and

Correlation & Price change

A.I.dvisor tells us that SNPHF and RHHVF have been poorly correlated (+7% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNPHF and RHHVF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPHF
1D Price
Change %
SNPHF100%
N/A
RHHVF - SNPHF
7%
Poorly correlated
+0.08%
PTKFY - SNPHF
6%
Poorly correlated
N/A
PTKFF - SNPHF
2%
Poorly correlated
N/A
RHHBY - SNPHF
2%
Poorly correlated
+1.13%
SNPHY - SNPHF
1%
Poorly correlated
-2.02%
More

SNPHY and

Correlation & Price change

A.I.dvisor tells us that SNPHY and RHHBF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNPHY and RHHBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPHY
1D Price
Change %
SNPHY100%
-2.02%
RHHBF - SNPHY
9%
Poorly correlated
+6.60%
RHHVF - SNPHY
9%
Poorly correlated
+0.08%
RHHBY - SNPHY
6%
Poorly correlated
+1.13%
OTSKY - SNPHY
3%
Poorly correlated
+0.96%
SNPHF - SNPHY
1%
Poorly correlated
N/A
More